Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_assertion type Assertion NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_head.
- NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_assertion description "[In the current study, we examined a panel of serially passaged glioblastoma xenografts, in the context of an intracranial tumor therapy response model, to identify associations between glioblastoma molecular characteristics and tumor sensitivity to the epidermal growth factor receptor (EGFR) kinase inhibitor erlotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_provenance.
- NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_assertion evidence source_evidence_literature NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_provenance.
- NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_assertion SIO_000772 17363510 NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_provenance.
- NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_assertion wasDerivedFrom befree-2016 NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_provenance.
- NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_assertion wasGeneratedBy ECO_0000203 NP599248.RAnZJkro5pUjlwpkflZ_3-T14tATeTKPkLD4BKxW77Gk8130_provenance.